Literature DB >> 10782164

Diagnostic value of immunocytochemistry in leptomeningeal tumor dissemination.

J E Thomas1, E Falls, M E Velasco, A Zaher.   

Abstract

Differentiating chronic aseptic meningitis from leptomeningeal carcinomatosis or gliomatosis can be difficult, particularly when the differentiation is based solely on routine cytologic examination. The diagnosis of cerebrospinal fluid tumor dissemination in at-risk patients requires cytologic examination of cerebrospinal fluid and radiography of the leptomeninges. Routine cytologic examination alone has proven less than desirable, in most instances providing confirmation in as little as 50% of cases in the first lumbar puncture. This percentage increases to 85% to 90% after multiple lumbar punctures. We retrospectively reviewed 2 cases of leptomeningeal dissemination (one gliomatosis, the other carcinomatosis) with initial false-negative test results. However, after further examination of the cerebrospinal fluid by selected battery of immunocytochemical stains, both cases were identified as positive for malignancy (ie, false negatives). Immunocytochemistry can be useful in distinguishing chronic aseptic meningitis from leptomeningeal carcinomatosis or gliomatosis in patients at risk or when abnormal cells are seen on routine cerebrospinal fluid cytologic examination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782164     DOI: 10.5858/2000-124-0759-DVOIIL

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  A case report and review of the literature.

Authors:  Shoji Yomo; Tsuyoshi Tada; Shuichi Hirayama; Naoko Tachibana; Masako Otani; Yuichiro Tanaka; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

2.  A Report of Two Cases of Leptomeningeal Carcinomatosis Arising from Gallbladder Carcinoma.

Authors:  Dinesh Chandra Doval; Saud Azam; Rupal Sinha; Ullas Batra; Anurag Mehta; Avinash Rao
Journal:  J Gastrointest Cancer       Date:  2015-12

3.  Solitary primary leptomeningeal glioma: case report.

Authors:  Young Goo Kim; Eui Hyun Kim; Se Hoon Kim; Jong Hee Chang
Journal:  Brain Tumor Res Treat       Date:  2013-04-30

Review 4.  Leptomeningeal metastases.

Authors:  Alexis Demopoulos
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

5.  Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.

Authors:  Juan P Fusco; Eduardo Castañón; Omar E Carranza; Leire Zubiri; Patricia Martín; Jaime Espinós; Javier Rodríguez; Marta Santisteban; José M Aramendía; Ignacio Gil-Bazo
Journal:  J Neurooncol       Date:  2013-09-15       Impact factor: 4.130

6.  Disseminated primary diffuse leptomeningeal gliomatosis: a case report with liquid based and conventional smear cytology.

Authors:  Masha Bilic; Cynthia T Welsh; Zoran Rumboldt; Rana S Hoda
Journal:  Cytojournal       Date:  2005-09-20       Impact factor: 2.091

7.  Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study.

Authors:  B Hildebrandt; C Müller; A Pezzutto; Pt Daniel; B Dörken; C Scholz
Journal:  BMC Cancer       Date:  2007-10-03       Impact factor: 4.430

8.  Treatment of Leptomeningeal Carcinomatosis in a Patient With Metastatic Cholangiocarcinoma.

Authors:  Ramon E A Jacobs; Katharine McNeill; Frank M Volpicelli; Karin Warltier; Eduardo Iturrate; Charles Okamura; Nicole Adler; Joshua Smith; Alana Sigmund; Aron Mednick; Benjamin Wertheimer; Katherine Hochman
Journal:  ACG Case Rep J       Date:  2014-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.